Indications for use of Miramistin are:

Surgery, traumatology: prevention of suppuration and treatment of purulent wounds; treatment of purulent-inflammatory processes of the musculoskeletal system. Obstetrics, gynecology: prevention and treatment of suppuration of postpartum injuries, perineal and vaginal wounds, postpartum infections; inflammatory diseases (vulvovaginitis, endometritis). Combustiology: treatment of superficial and deep burns of II and IIIA degrees; preparation of burn wounds for dermatoplasty. Dermatology, venereology: treatment and prevention of pyoderma and dermatomycosis, candidiasis of the skin and mucous membranes, mycoses of the feet. Individual prevention of sexually transmitted diseases (syphilis, gonorrhea, chlamydia, trichomoniasis, genital herpes, genital candidiasis, etc.). Urology: complex treatment of acute and chronic urethritis and urethroprostatitis of a specific (chlamydia, trichomoniasis, gonorrhea) and non-specific nature. Dentistry: treatment and prevention of infectious and inflammatory diseases of the oral cavity: stomatitis, gingivitis, periodontitis, periodontitis. Hygienic treatment of removable dentures. Otorhinolaryngology: complex treatment of acute and chronic otitis media, sinusitis, tonsillitis, laryngitis.

  Pharmachologic effect:

Miramistin has a pronounced bactericidal effect against gram-positive and gram-negative, aerobic and anaerobic bacteria in the form of monocultures and microbial associations, including hospital strains with multidrug resistance to antibiotics. The drug is more effective against gram-positive bacteria (Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae, etc.), acts on sexually transmitted diseases (Chlamydia spp., Treponema spp., Trichomonas vaginalis, Neisseria gonorrhoeae), and viruses of herpes, human immunodeficiency, etc. Has an antifungal effect on ascomycetes of the genus Aspergillus and genus Penicillium, yeast fungi (Rhodotorula rubra, Torulopsis gabrata, etc.) and yeast-like (Candida albicans, Candida tropicalis, Candida krusei, etc.) , dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violacent, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis, etc.), pathogenic also Malassezia furfur), in the form of monocultures and microbial associations, including fungal microflora with resistance to chemother apeutic drugs. Effectively prevents infection of wounds and burns, activates regeneration processes. It has a pronounced hyperosmolar activity, as a result of which it relieves wound and perifocal inflammation, absorbs purulent exudate, contributing to the formation of a dry scab. Does not damage granulation and viable skin cells, does not inhibit marginal epithelization. Does not possess local irritating effect and allergenic properties. Pharmacokinetics. When applied topically, miramistin does not have the ability to be absorbed through the skin and mucous membranes.